Neurotech - Company Information on Neurotech

Press Enter or Click Search to perform a full site search.

Company Name Matches

Show All Search Results »

Companies>Neurotech

Add to Watch List Share This Page

Email Page Flag This Page

Flag

Headline: Noval Therapies for the Eye

Website: http://www.neurotechusa.com/

Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology. Neurotech’s lead product (NT-501) is in clinical development for the treatment of retinal degeneration, including retinitis...More»

Address: 701 George Washington Highway Lincoln, RI 02865 Map it »

Phone: 401-333-3880

Email: contact@neurotechusa.com

Industry: Other Healthcare

Sub-Industry: Healthcare Services

Tags:

Add a tag

Management

Board of Directors

Advisors

Date	Type	Capital Amount	Post-Money Valuation	Investors
09/2006	Series B	35M	Unknown	Versant Ventures, Merlin BioSciences, Atlas Ventures, Omega, SV Life Sciences, Burrill and Company, Pound Capital, Nexus Medical Partners, Apax Partner

Name:	NT-501 Retinis Pigmentosa
Product URL:	http://www.neurotechusa.com/product_apps.asp
Description:	Neurotech's lead product, NT-501, consists of encapsulated human cells genetically modified to secrete ciliary neurotrophic factor (CNTF). NT-501 is designed to continually deliver a low, safe and therapeutic dose of CNTF, a well-established neurotrophic factor, into the back of the eye. The Company believes that CNTF activates dying retinal photoreceptors and protects them from degeneration.